Photronics is a semiconductor photomask manufacturer, and its analyst coverage remains modest. Four current, attributed analyst price targets were reviewed: Lake Street at $44 (Buy, August 2026), Freedom Capital Markets at $41 (Buy, July 2026), Craig-Hallum at $42 (Buy, May 2026), and D.A. Davidson at $45 (Buy, December 2025). Their arithmetic mean is $43, which serves as the central target here. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The range is notably narrow — $41 to $45 — so the central $43 figure fairly represents where the sell side clusters rather than reflecting an outlier. All four analysts rate the stock a Buy, with none carrying a Hold or Sell. Aggregators report slightly different figures depending on timing; for example, S&P Global's three-analyst average is near $41, while some older screens still include a superseded $55 figure. The key point remains that current, attributable targets sit tightly in the low-to-mid $40s, justified on valuation and a recovery in high-end mask demand rather than aggressive growth assumptions.
Photronics shares closed near $28.92, giving the company a market value of roughly $1.7 billion. The stock trades at a trailing P/E near 10 and a 52-week range of $20.05 to $56.00, meaning it has fallen roughly 48% from its high. Reaching $43 would require about a 49% advance — a very large move relative to the current price.
That path would most plausibly run through a sustained recovery in high-end integrated circuit (IC) photomasks. In its fiscal third quarter of 2026, Photronics reported revenue of about $216 million, up 2.7% year over year, and non-GAAP EPS of $0.50, well above consensus near $0.40. High-end products reached a record 44% of IC revenue, and management pointed to a recovery of previously delayed semiconductor design releases. For the fiscal fourth quarter, the company guided to revenue of $207–$227 million and non-GAAP EPS of $0.40–$0.56 — a wide range reflecting limited visibility.
Several verified factors could underpin a recovery. Demand for leading-edge memory and logic chips tied to AI applications is a multiyear growth driver, and photomasks are the templates used to print every chip design. Photronics is expanding capacity in the United States (Allen, Texas, and Boise, Idaho) and Korea, and its display segment is benefiting from complex AMOLED mask demand. The company also holds roughly $673 million in cash and short-term investments, providing balance-sheet flexibility, and its valuation is inexpensive relative to historical levels. A clean balance sheet, a record high-end product mix, and analyst Buy ratings all support the case that the shares could re-rate higher.
The main obstacle is visibility. Management has said order backlogs span only one to three weeks, so a few delayed design releases can swing quarterly results. Heavy capital spending, while guided lower to $255–$305 million for fiscal 2026 from $330 million, still pressures near-term free cash flow. The mainstream IC business has been soft, local competition in China remains concentrated in mainstream masks, and memory-supply constraints plus geopolitical factors cloud the outlook. Separately, securities-fraud investigations announced by law firms have added an overhang. Finally, a stock trading near $29 after peaking at $56 must overcome substantial technical overhead before any move toward the low-$40s can build.
The shares sit in the lower half of a wide trading range. The 52-week high near $56 is a distant but meaningful resistance level, while the 52-week low near $20.05 marks the downside extreme. Market commentary has identified the low-to-mid $30s — around $34.50 — as a near-term resistance zone that previously capped consolidation, and the high-$20s as an area where institutional buyers have stepped in. A durable break above the mid-$30s would be an early technical signal that a longer recovery toward the low-$40s is underway, whereas a failure to hold the high-$20s would keep the stock in its recent downtrend.
Analyst price targets typically reflect a research horizon of about 12 months, though the exact horizon can vary by firm and none of the targets reviewed here specifies a precise date. The next material catalyst is Photronics' fiscal fourth-quarter and full-year results, expected in December 2026. Investors should monitor revenue and EPS against guidance, the high-end IC mix, commentary on capacity ramps in the U.S. and Korea, capital-expenditure discipline, and any analyst revisions. Broader semiconductor demand, memory pricing, and any resolution of the legal investigations will also shape whether the stock can close the gap toward the $43 target.
When reviewing names like this, I sometimes cross-check technical signals with Tickeron’s AI Daily Buy/Sell Signals to get an additional data-driven perspective on momentum and trend shifts.
Can Photronics reach $43? The target is not a forecast but the average of four current Buy-rated analyst targets spanning $41 to $45. Reaching it would require a roughly 49% advance from about $28.92 — a very large move supported by recovering high-end photomask demand, a strong cash position, and a low valuation, but challenged by limited order visibility, heavy capital spending, and legal overhangs. The tight clustering of analyst targets signals conviction that the shares are undervalued, yet the wide revenue guidance and short backlog underscore genuine uncertainty. The fiscal fourth-quarter report due in December, along with analyst revisions and semiconductor demand trends, will be the clearest indicators of whether a move toward $43 becomes realistic.
One tool I find particularly useful for tracking stocks like this is Tickeron’s AI Daily Buy/Sell Signals. It uses artificial intelligence to monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions and technical behavior. Rather than replacing judgment, the tool helps discover opportunities, monitor positions, and spot shifting trends more efficiently, adding a disciplined, data-driven layer to the decision process for volatile names such as Photronics.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
PLAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 37 of 40 cases where PLAB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PLAB's RSI Oscillator exited the oversold zone, 24 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 66 cases where PLAB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on PLAB as a result. In 61 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
PLAB moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +13.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where PLAB advanced for three days, in 219 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence Histogram (MACD) for PLAB turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 37 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
The 10-day moving average for PLAB crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLAB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
The Aroon Indicator for PLAB entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.260) is normal, around the industry mean (5.670). P/E Ratio (9.668) is within average values for comparable stocks, (68.795). Projected Growth (PEG Ratio) (1.000) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.880) is also within normal values, averaging (27.897).
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. PLAB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 64 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of photomasks used in making semiconductors
Industry ElectronicProductionEquipment